Amf Tjanstepension Ab Novo Cure LTD Transaction History

Amf Tjanstepension Ab

  • $13.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022
SELL
$67.99 - $89.57 $1.7 Million - $2.24 Million
-24,953 Reduced 35.29%
45,755 $3.48 Million
Q2 2022

Jul 26, 2022
BUY
$56.6 - $89.9 $4 Million - $6.36 Million
70,708 New
70,708 $4.91 Million
Q3 2021

Nov 03, 2021
SELL
$116.17 - $194.55 $6.82 Million - $11.4 Million
-58,696 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$130.4 - $225.58 $7.65 Million - $13.2 Million
58,696 New
58,696 $13 Million

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.15B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Amf Tjanstepension Ab Portfolio

Follow Amf Tjanstepension Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amf Tjanstepension Ab, based on Form 13F filings with the SEC.

News

Stay updated on Amf Tjanstepension Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email